Healthcare & Medical Devices Global On demand · 24-48h

Global Pulse-chase Analysis Market Strategic Research Report

Global Pulse-chase Analysis Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pulse-chase Analysis Market
$8012025
9.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Radioactive Isotope Labeling, Fluorescent Labeling, Mass Spectrometry Labeling, Others

By Application: Biomedical Research and Development, Scientific Research and Education, Clinical Diagnosis, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Charles River Laboratories, WuXi AppTec, Pharmaron, Eurofins Discovery, Sygnature Discovery, BioDuro, ChemPartner, Selvita, Reaction Biology, Domainex, CellCarta, HitGen, Oncodesign Services, BPS Bioscience, Creative Biolabs

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 107 pages
Market size 2025
$801
Million USD
Forecast CAGR
9.3%
2025-2032
Forecast 2032
$1492.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Pulse-chase Analysis market size is predicted to grow from US$ 801 million in 2025 to US$ 1,482 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.

Pulse-chase Analysis is a classic experimental method in cells or biological systems that uses short-term labeling (Pulse) followed by label-free tracing (Chase) to study the dynamic processes of molecular (such as protein, RNA, metabolite) synthesis, transport, processing and degradation.

Gross Profit Margin Level

Pulse tracking analysis is not a standardized, low-barrier-to-entry routine testing service. Instead, it is a specialized research service embedded in high-tech projects such as protein half-life determination, protein degradation kinetics studies, ribonucleic acid synthesis and degradation rate analysis, and drug action mechanism verification. Therefore, its profit model is closer to "customized life science outsourcing services + high-end omics analysis services" than ordinary experimental testing. These projects typically involve cell model construction, metabolic labeling, time-series sampling, mass spectrometry or sequencing detection, and subsequent data analysis and mechanism interpretation. The technical barriers are high, and clients have stronger requirements for the quality and interpretability of the results. Overall, the gross profit margin of this sub-segment is usually higher than that of general experimental outsourcing services. The industry's overall gross profit margin can be roughly estimated in the range of 45%–60%. Among them, ribonucleic acid kinetics and sequencing services, which have more standardized processes and higher reproducibility, often have higher gross profit margins, reaching 55%–70%; while projects relying on complex cell models, special labeling systems, customized experimental designs, and multiple rounds of validation typically have gross profit margins closer to 35%–50%. Overall, this is a niche service market that, while not particularly large in scale, boasts high technology density, high average order value, and profitability superior to general testing outsourcing.

Industry Drivers

The core driver of growth in this niche is primarily the continued surge in research and development of targeted protein degradation drugs. Pharmaceutical companies and biotechnology firms are no longer content with simply verifying whether compounds bind to targets; they are increasingly focused on whether target proteins actually degrade, how fast they degrade, whether they exhibit sufficient selectivity, and whether degradation triggers changes in downstream pathways. This directly drives the growth in demand for protein degradation kinetics, protein turnover analysis, and related omics outsourcing. Simultaneously, RNA kinetics research is expanding, with more and more research institutions and companies seeking to directly measure the relationship between newly generated RNA and existing RNA to analyze gene regulation, drug response, transcriptional activity, and RNA stability. Furthermore, as life science research gradually shifts from "static expression analysis" to "dynamic process analysis," the market demand for technologies capable of revealing molecular lifecycles and temporal changes has significantly increased. On the other hand, these types of experiments are usually infrequent, have high technical barriers, and require strong platform capabilities. As a result, more and more clients tend to outsource them to platform service providers with mature systems and experience, which has also driven the continued rapid growth of this field.

This report presents a comprehensive overview of the global Pulse-chase Analysis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Radioactive Isotope Labeling
  • Fluorescent Labeling
  • Mass Spectrometry Labeling
  • Others

Segment by Experimental Scale

  • Microanalytical Analysis
  • Routine Analytical Analysis
  • Others

Segment by Detection Technology

  • Imaging Analysis
  • Separation Analysis
  • Counting Analysis
  • Others

Segment by Application

  • Biomedical Research and Development
  • Scientific Research and Education
  • Clinical Diagnosis
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pulse-chase Analysis market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biomedical Research and Development, Scientific Research and Education, Clinical Diagnosis evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pulse-chase Analysis Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$801
2025
Forecast
$1492.7
2032
CAGR
9.3%
2025–2032
Regions
5
global
Key companies
Charles River LaboratoriesWuXi AppTecPharmaronEurofins DiscoverySygnature DiscoveryBioDuroChemPartnerSelvita
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Radioactive Isotope LabelingFluorescent LabelingMass Spectrometry LabelingOthers
By Application
Biomedical Research and DevelopmentScientific Research and EducationClinical DiagnosisOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Radioactive Isotope Labeling
  • 3.1.3 Fluorescent Labeling
  • 3.1.4 Mass Spectrometry Labeling
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biomedical Research and Development
  • 4.1.3 Scientific Research and Education
  • 4.1.4 Clinical Diagnosis
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Charles River Laboratories
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 WuXi AppTec
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Pharmaron
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Eurofins Discovery
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sygnature Discovery
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BioDuro
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ChemPartner
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Selvita
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Reaction Biology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Domainex
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 CellCarta
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 HitGen
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Oncodesign Services
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 BPS Bioscience
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Creative Biolabs
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Pulse-chase Analysis market size?
The global Pulse-chase Analysis market is estimated at US$ 801 million in 2025 (base year) and is projected to reach US$ 1.48 billion by 2032.
What growth rate is expected for the Pulse-chase Analysis market through 2032?
The market is expected to grow at a CAGR of 9.3% from 2026 to 2032, expanding from US$ 801 million in 2025 to US$ 1.48 billion in 2032, roughly 1.8 times its base-year value.
How is Pulse-chase Analysis defined?
Pulse-chase Analysis is a classic experimental method in cells or biological systems that uses short-term labeling (Pulse) followed by label-free tracing (Chase) to study the dynamic processes of molecular (such as protein, RNA, metabolite) synthesis, transport, processing and degradation.
What are the main segments of the Pulse-chase Analysis market by type?
By type, the market is segmented into Radioactive Isotope Labeling, Fluorescent Labeling, Mass Spectrometry Labeling and Others.
Which applications drive demand in the Pulse-chase Analysis market?
Key applications covered include Biomedical Research and Development, Scientific Research and Education, Clinical Diagnosis and Others.
Who are the key players in the Pulse-chase Analysis market?
Key players profiled include Charles River Laboratories, WuXi AppTec, Pharmaron, Eurofins Discovery, Sygnature Discovery, BioDuro, ChemPartner and Selvita, among 15 companies covered in total.
Which regions and countries are covered for Pulse-chase Analysis?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Pulse-chase Analysis market?
This directly drives the growth in demand for protein degradation kinetics, protein turnover analysis, and related omics outsourcing.
What challenges does the Pulse-chase Analysis market face?
Pulse tracking analysis is not a standardized, low-barrier-to-entry routine testing service.
Who should buy the Pulse-chase Analysis market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biomedical Research and Development, Scientific Research and Education and Clinical Diagnosis, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pulse-chase Analysis market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.